Noonan Spectrum Disorders Panel

Last Literature Review: February 2019 Last Update:

Confirm a suspected clinical diagnosis of:

  • Noonan syndrome (NS)
  • Cardiofacial cutaneous syndrome (CFCS)
  • Costello syndrome (CS)
  • Legius syndrome (LS)
  • Noonan syndrome with multiple lentigines (LEOPARD syndrome)
  • Noonan-like syndrome
  • Noonan-like syndrome with loose anagen hair (NS/LAH)

Given the genotypic and phenotypic overlap among NSDs, the NSD panel is the recommended first-line test for determining a genetic etiology. 

Contraindications: This panel should not be ordered in individuals with primary juvenile myelomonocytic leukemia (JMML) as the assay may not detect mosaicism for somatic variants associated with malignancy.

Confirm a diagnosis of an NSD in a pregnancy with clinically suggestive findings, such as increased nuchal translucency, cystic hygroma, and cardiac defects. For a fetus with ultrasonographic abnormalities, genomic microarray should be ordered prior to the NSD panel.

If a familial sequence variant has been previously identified, targeted sequencing for that variant may be appropriate; refer to the Laboratory Test Directory for additional information.

Noonan spectrum disorders (NSDs) are a group of genetic syndromes caused by pathogenic germline variants in genes in the Ras/mitogen activated protein kinase (MAPK) pathway, which controls the cell cycle and cell differentiation. The vast majority of causative variants increase pathway signaling; thus, the resulting syndromes exhibit phenotypic overlap and share a predisposition for developing malignancies.

Disease Overview

Symptoms of Noonan Syndrome (NS)

  • Characteristic facial features
  • Short stature
  • Broad webbed neck (fetal cystic hygroma/increased nuchal translucency)
  • Congenital heart defect
  • Developmental delay
  • Undescended testes
  • Coagulation defects
  • Lymphatic dysplasias

Etiology of NSDs

Pathogenic sequence variants in Ras pathway genes

Prevalence

NS: 1/1,000-2,500

Inheritance

Autosomal dominant for all analyzed genes

Genotype-Phenotype Correlation

Variants in multiple genes cause overlapping phenotypes for NSD

Test Description

See Genes Tested table for genes included in this panel.

Clinical Sensitivity

Dependent on clinical phenotype

  • Approximately 99% for cardiofaciocutaneous syndrome (CFCS) 
  • Approximately 80-90% for Costello syndrome (CS) , , , 
  • Approximately 70-80% for NS - 

Limitations

  • A negative result does not exclude a diagnosis of a MAPK pathway disorder.
  • Diagnostic errors can occur due to rare sequence variations.
  • Interpretation of this test result may be impacted if the individual has had an allogeneic stem cell transplantation.
  • The following will not be evaluated:
    • Variants outside the coding regions and intron-exon boundaries of the targeted genes
    • Regulatory region variants and deep intronic variants
    • Large deletions/duplications
    • Noncoding transcripts
  • The following may not be detected:
    • Deletions/duplications/insertions of any size by massively parallel sequencing
    • Some variants due to technical limitations in the presence of pseudogenes, repetitive, or homologous regions
    • Low-level somatic variants

Analytic Sensitivity

For massively parallel sequencing:

Variant ClassAnalytic Sensitivity (PPA) Estimatea (%)Analytic Sensitivity (PPA) 95% Credibility Regiona (%)
SNVs99.296.9-99.4
Deletions 1-10 bp93.884.3-98.2
Deletions 11-44 bp10087.8-100
Insertions 1-10 bp94.886.8-98.5
Insertions 11-23 bp10062.1-100
bp, base pairs; PPA, positive percent agreement; SNVs, single nucleotide variants

Genes Tested

GeneAlias Symbol(s)MIM NumberDisorder
BRAFBRAF1164757

CFCS 1

NS 1

NS 7

LEOPARD syndrome 3

CBLCBL2, RNF55, c-Cbl165360NS-like disorder with or without juvenile myelomonocytic
HRASHRAS1190020

Melanocytic Nevus syndrome, congenital

Schimmelpenning-Feuerstein-Mims syndrome

CS

KRASKRAS2, KRAS1190070

Schimmelpenning-Feuerstein-Mims syndrome

NS 3

CFCS 2

LZTR1LZTR-1, BTBD29600574NS 10
MAP2K1PRKMK1, MEK1, MAPKK1176872

NS 1

CFCS 3

MAP2K2PRKMK2, MEK2601263CFCS 4
NRASN-ras164790

Schimmelpenning-Feuerstein-Mims syndrome

NS 6

PTPN11NS1, BPTP3, SH-PTP2, SHP-2, PTP2C, SHP2176876

LEOPARD syndrome 1

NS 1

RAF1Raf-1, c-Raf, CRAF164760

NS 5

LEOPARD syndrome 2

RASA2GAP1M601589 
RIT1RIT, RIBB, ROC1, MGC125864, MGC125865609591NS 8
SHOC2KIAA0862, SOC2, SUR-8, SOC-2, SUR8602775NS-like disorder with loose anagen hair 1
SOS1GINGF, HGF, GF1182530NS 4
SOS2 601247NS 9
SPRED1FLJ33903, PPP1R147609291Legius syndrome

References